Characterizing Clinical and Pharmacological Neuroimaging Biomarkers
Status:
Completed
Trial end date:
2018-08-31
Target enrollment:
Participant gender:
Summary
This study is part of a larger overall study that seeks to characterize clinical and
pharmacological neuroimaging biomarkers. The purpose of this registered protocol is
understand the effect of emotion on cognitions by specifically examining the effect of reward
processing on working memory in patients with schizophrenia.